ArticleArthroplasty (London, England)2026
Radiographic features of bone ingrowth in highly porous cementless total knee arthroplasty with minimum 2-year follow-up.
Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe definition of successful osteointegration after cementless total knee arthroplasty (TKA) remains uncertain. We hypothesize that trabecular line formation, bone resorption, and radiolucent line (RLL) disappearance follow a temporal pattern after cementless TKA.
methodsThis is a single-institution retrospective radiographic study involving 221 consecutive patients (301 knees) who had undergone robotic-assisted cementless TKA for primary knee osteoarthritis. All patients had a minimum of 2 years of follow-up (mean 46.5 ± 12.4 months). All TKAs consisted of a 3D-printed titanium-coated tibial tray and cobalt chromium-coated femoral component, which were highly porous, allowing for biologic fixation. Primary outcomes were incidences of trabecular line formation, early radiolucent lines (RLL), and bone resorption. Secondary outcomes were (1) the temporal relationship in RLL disappearance, trabecular line formation, and bone resorption, (2) the relationship between factors with osteointegration, and (3) mid-term clinical outcomes in terms of radiographic alignment, postoperative complications, and revision rates.
resultsTrabecular line formation was observed in 90.4% of knees and was most commonly seen medial (67.2%) and lateral (36.9%) to the tibial keel. RLLs were observed immediately following surgery in 33.6% of knees and were most common at the femoral anterior chamfer region, while bone resorption was most commonly found at the femoral anterior chamfer (41.2%) and the medial tibia (36.5%), indicating a stress shielding effect. Overall, new trabecular line formation occurred early in the postoperative course at an average of 4.5 ± 4.1 months, with bone resorption at a far later stage of 16.2 ± 11.4 months. In knees with early RLL (n = 101), disappearance of RLL occurred at a mean of 8.9 ± 8.6 months postop and was preceded by trabecular bridging. In knees without early RLLs (n = 200), trabecular line formation occurred at an average of 4.0 ± 3.3 months postop, which occurred at an earlier time point than knees with early RLLs (p = 0.009). Timing of bone resorption did not differ significantly between groups (p = 0.221). Radiographic alignment was maintained at post-op > 2 years with only two cases (0.7%) of revisions recorded.
conclusionsIn highly porous cementless TKAs with a 3D-printed titanium-coated implant system, bone ingrowth in the form of new trabeculae was observed in > 90% of knees, pointing towards satisfactory osteointegration. Osteointegration typically occurred between 4.5 and 8.9 months, with trabecular line formation and RLL disappearance. Bone remodeling from the stress shielding effect continued beyond 14 months, leading to zones of bone resorption. LEVEL OF EVIDENCE: Level III (retrospective study).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.